Teladoc Sees Q4 2021 Revs $536M-$546M Vs $539.74M Est
For the fourth-quarter 2021, we expect:
Total revenue to be in the range of $536 million to $546 million.
EBITDA to be in the range of $(8) million
Teladoc Health Q3 EPS $(0.53) Beats $(0.65) Estimate, Sales $521.66M Beat $516.63M Estimate
Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.65) by 18.46 percent. This is a 307.69 percent decrease over losses of $(0.13) per share from the
Earnings Scheduled For October 27, 2021
Companies Reporting Before The Bell
• McDonald's (NYSE:MCD) is expected to report quarterly earnings at $2.46 per share on revenue of $6.03 billion.
Wells Fargo Initiates Coverage On Teladoc Health with Overweight Rating, Announces Price Target of $156
Wells Fargo analyst Stephen Baxter initiates coverage on Teladoc Health (NYSE:TDOC) with a Overweight rating and announces Price Target of $156.
Cathie Wood Piled Up Another $994K In This Company Linked With Elon Musk’s SpaceX On Friday
Cathie Wood-led Ark Investment Management on Friday bought 126,360 shares — estimated to be worth about $994,453 — in Velo3D Inc (NYSE: VLD), on the dip.
Cathie Wood’s ARK Invest Posts Fund Purchases For Tuesday, Oct. 12 2021: TDOC, CRSP, NTLA, SSYS, MKFG, BLDE, VLD, GENI, TWOU, CDNA, ARCT, SLGC, BEAM, QSI, DYNS
Teladoc Health (TDOC) - 198,681 Shares
CRISPR Therapeutics (CRSP) - 61,732
Intellia Therapeutics (NTLA) - 13,254
Stratasys (SSYS) - 26,989
Markforged (MKFG) - 179,691
Blade Air Mobility (BLDE) - 94,782
Velo3D
Cathie Wood’s ARK Invest Posts Fund Purchases For Monday, Oct. 11, 2021: TDOC, CRSP, NTLA, NIU, BLDE, MKFG, VLD, TWOU, GENI, BEAM, SLGC, CDNA, QSI, ACHR
Teladoc Health (TDOC) - 211,626
CRISPR Therapeutics (CRSP) - 248,148
Intellia Therapeutics (NTLA) - 37,991
Niu Technologies (NIU) - 159,329
Blade Air Mobility (BLDE)
10 Health Care Stocks With Unusual Options Alerts In Today’s Session
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Unusual trading activity could push option prices to hyperbolic or underperforming levels.
Cathie Wood’s ARK Invest Posts Fund Purchases For Tuesday, Oct. 5, 2021: TDOC, PACB, BEAM, SGFY, TWOU, DNA, SSYS, MKFG, ACHR, BLDE, VLD, NIU, SQ, VUZI, ADPT, SURF, QSI, SLGC, MASS, DYNS, PATH, HOOD, TOST, PRNT
Teladoc Health (TDOC) - 154,175 Shares
Pacific Biosciences Of California (PACB) - 783,580
Beam Therapeutics (BEAM) - 104,491
Signify Health (SGFY) - 749,117
2U (TWOU) - 166,427
Gingko Bioworks (DNA) -